Prestige Wealth Management Group LLC Belite Bio, Inc Put Options Transaction History
Prestige Wealth Management Group LLC
- $456 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BLTE
# of Institutions
24Shares Held
278KCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY168KShares$9.4 Million0.15% of portfolio
-
State Street Corp Boston, MA20KShares$1.12 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC18.3KShares$1.03 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY14.6KShares$819,6160.0% of portfolio
-
Ubs Group Ag12.2KShares$683,5920.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.39B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...